Changes in Serum Osteocalcin are Not Associated with Changes in Glucose or Insulin for Osteoporotic Patients Treated with Bisphosphonate

BACKGROUND: Bisphosphonate is used in osteoporosis treatment to repress osteoclast activity, which then decreases levels of osteocalcin (OC). OC, a protein secreted by osteoblasts and released from the bone matrix during osteoclastic bone resorption, has been found to control blood glucose levels by...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Seong-hun, Koo, Ja-won, Hwang, Jin Kyung, Hwang, You-Cheol, Jeong, In-Kyung, Ahn, Kyu Jeung, Chung, Ho-Yeon, Kim, Deog-Yoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Bone and Mineral Research 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3780832/
https://www.ncbi.nlm.nih.gov/pubmed/24524054
http://dx.doi.org/10.11005/jbm.2013.20.1.37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3780832/
https://www.ncbi.nlm.nih.gov/pubmed/24524054
http://dx.doi.org/10.11005/jbm.2013.20.1.37

Ejemplares similares